These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19471207)

  • 1. Modeling the LPS neutralization activity of anti-endotoxins.
    Thippakorn C; Suksrichavalit T; Nantasenamat C; Tantimongcolwat T; Isarankura-Na-Ayudhya C; Naenna T; Prachayasittikul V
    Molecules; 2009 May; 14(5):1869-88. PubMed ID: 19471207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ultrastructural morphology of endotoxins and lipopolysaccharides.
    Brogden KA; Phillips M
    Electron Microsc Rev; 1988; 1(2):261-78. PubMed ID: 3155022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial endotoxin: molecular relationships between structure and activity.
    Rietschel ET; Seydel U; Zähringer U; Schade UF; Brade L; Loppnow H; Feist W; Wang MH; Ulmer AJ; Flad HD
    Infect Dis Clin North Am; 1991 Dec; 5(4):753-79. PubMed ID: 1723739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to lipopolysaccharide.
    Poxton IR
    J Immunol Methods; 1995 Oct; 186(1):1-15. PubMed ID: 7561138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
    Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pushing the envelope: LPS modifications and their consequences.
    Simpson BW; Trent MS
    Nat Rev Microbiol; 2019 Jul; 17(7):403-416. PubMed ID: 31142822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
    Giordano NP; Cian MB; Dalebroux ZD
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical structure, molecular conformation, and bioactivity of endotoxins.
    Seydel U; Schromm AB; Blunck R; Brandenburg K
    Chem Immunol; 2000; 74():5-24. PubMed ID: 10608079
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacterial endotoxins: relationship between chemical structure and biological effect].
    Rietschel ET; Brade L; Schade FU; Seydel U; Zähringer U; Mamat U; Schmidt G; Ulmer AJ; Loppnow H; Flad HD
    Immun Infekt; 1993 Apr; 21(2):26-35. PubMed ID: 8340135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccaride-binding peptides obtained by phage display method.
    Matsumoto M; Horiuchi Y; Yamamoto A; Ochiai M; Niwa M; Takagi T; Omi H; Kobayashi T; Suzuki MM
    J Microbiol Methods; 2010 Jul; 82(1):54-8. PubMed ID: 20412822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization.
    Mangoni ML; Epand RF; Rosenfeld Y; Peleg A; Barra D; Epand RM; Shai Y
    J Biol Chem; 2008 Aug; 283(34):22907-17. PubMed ID: 18550541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15(2):133-41. PubMed ID: 2439461
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of cytokines in endotoxic shock and in endotoxin hypersensitivity].
    Freudenberg MA; Ness T; Kumazawa Y; Galanos C
    Immun Infekt; 1993 Apr; 21(2):40-4. PubMed ID: 8340136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules.
    David SA
    J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.
    Mascelli MA; Frederick B; Ely T; Neblock DS; Shealy DJ; Pak KY; Daddona PE
    Infect Immun; 1993 May; 61(5):1756-63. PubMed ID: 8478065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15 Suppl 2():S76-84. PubMed ID: 2440812
    [No Abstract]   [Full Text] [Related]  

  • 19. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.
    Heumann D; Lauener R; Ryffel B
    J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.